RDNT
RadNet, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$60.68-2.43%
Price as of Jul 20, 2026
RDNT financials
RadNet, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $2.0B | $1.8B | $1.6B | $1.4B |
| Cost of revenue | $1.9B | $1.6B | $1.4B | $1.3B |
| Gross profit | $90.8M | $249.1M | $221.4M | $165.7M |
| Operating expenses | $0.00 | $144.5M | $122.7M | $119.4M |
| Operating income | $90.8M | $104.6M | $98.7M | $46.4M |
| Net income | -$18.7M | $2.8M | $3.0M | $10.7M |
| EBITDA | $253.9M | $262.5M | $292.8M | $278.5M |
| Basic EPS | $-0.25 | $0.04 | $0.05 | $0.19 |
| Diluted EPS | $-0.25 | $0.04 | $0.05 | $0.17 |
| Balance sheet | ||||
| Cash & equivalents | $767.2M | $740.0M | $342.6M | $127.8M |
| Total assets | $3.8B | $3.3B | $2.7B | $2.4B |
| Total liabilities | $2.4B | $2.2B | $1.9B | $1.9B |
| Stockholders’ equity | $1.1B | $902.3M | $630.7M | $333.0M |
| Total debt | $1.9B | $1.7B | $1.5B | $1.5B |
| Net debt | $1.1B | $988.8M | $1.1B | $1.4B |
| Cash flow | ||||
| Operating cash flow | $298.8M | $233.0M | $220.9M | $146.4M |
| Capital expenditure | -$213.3M | -$188.1M | -$176.6M | -$249.4M |
| Free cash flow | $85.6M | $45.0M | $44.3M | -$103.0M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |